Tarriff Scott 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Tarriff Scott
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2023-02-28$28.00/sh−3,113$87,164→ 1,569,034 total - Award
Common Stock
2023-03-01+70,900→ 1,639,934 total
Footnotes (2)
- [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
- [F2]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of March 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.